CAS 71203-35-5

4-[5-(4-Methoxyphenyl)-3-phenyl-4,5-dihydropyrazol-1-yl]benzenesulfonamide

CAS: 71203-35-5

Formel: C₂₂H₂₁N₃O₃S

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 407.4854

Ref: IN-DA00FC1N

ML141

CAS: 71203-35-5

ML141

Reinheit: ≥98%

Molekulargewicht: 407.49g/mol

Ref: 54-BUP07931

ML141

CAS: 71203-35-5

ML141 (CID-2950007) is an effective, specific and reversible non-competitive inhibitor of Rho family GTPase cdc42 (IC50: 200 nM).

Formel: C₂₂H₂₁N₃O₃S

Reinheit: 99.36% - 99.56%

Farbe und Form: Solid

Molekulargewicht: 407.49

Ref: TM-T2463

ML141

Kontrolliertes Produkt

CAS: 71203-35-5

Applications ML141 is a potent selective reversible non-competitive inhibitor of Rho family GTPase use in the treatment of bacterial infections.
References Hong, L. et al.: J. Biol. Chem., 288, 8531 (2013)

Formel: C₂₂H₂₁N₃O₃S

Farbe und Form: Neat

Molekulargewicht: 407.485

Ref: TR-M425250

Cdc42/Rac1 GTPase Inhibitor, ML141

CAS: 71203-35-5

Cdc42/Rac1 GTPase Inhibitor, ML141, is a small molecule inhibitor, which is a synthetic compound specifically designed to interfere with cellular processes. Originating from high-throughput screening and medicinal chemistry optimization, this inhibitor functions by selectively targeting the Rho family of GTPases, specifically Cdc42 and Rac1. These GTPases play crucial roles in regulating the actin cytoskeleton, cell movement, and growth signaling pathways.

Formel: C₂₂H₂₁N₃O₃S

Reinheit: Min. 95%

Molekulargewicht: 407.49 g/mol

Ref: 3D-WCA20335